Grace Therapeutics

(NASDAQ) GRCE

Current Price$2.57

Market Cap$37.60M

Since IPO (2011)-100%

5 YearN/A

1 Year-11%

1 Month+22%

Grace Therapeutics Financials at a Glance

Market Cap

$37.60M

Revenue (TTM)

$0.00

Net Income (TTM)

-$8.16M

EPS (TTM)

-$0.36

P/E Ratio

-6.74

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$2.57

Volume

418,452.716

Open

$2.43

Price

$2.57

Volume

418,452.716

Open

$2.43

Previous Close

$2.57

Daily Range

$2.40 - $2.60

52-Week Range

$1.79 - $5.18

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$2.57

Volume

418,452.716

Open

$2.43

Previous Close

$2.57

Daily Range

$2.40 - $2.60

52-Week Range

$1.79 - $5.18

GRCE News

Why Shares of Acasti Pharma Slumped Tuesday

James HalleyAug 31, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Grace Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Prashant Kohli, MBA

Website

www.gracetx.com

Headquarters

Princeton, NJ 08540, US

GRCE Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-10%

Return on Capital

-23%

Return on Assets

-12%

Earnings Yield

-14.84%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$37.60M

Shares Outstanding

15.47M

Volume

418.45K

Avg. Volume

787.95K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$23.75M

EBITDA

-$23.74M

Operating Cash Flow

-$14.90M

Capital Expenditure

$0.00

Free Cash Flow

-$14.90M

Cash & ST Invst.

$22.13M

Total Debt

$0.00

Grace Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$37.60M

N/A

Market Cap/Employee

$9.40M

N/A

Employees

N/A

Net Income

-$3.18M

+46.8%

EBITDA

-$3.36M

+37.0%

Quarterly Fundamentals

Name

Q3 2026YOY CHG

Net Cash

$18.67M

+68.9%

Accounts Receivable

$20.00K

-93.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-11.91%

N/A

Return on Invested Capital

-23.26%

N/A

Free Cash Flow

-$2.22M

+46.1%

Operating Cash Flow

-$2.22M

+46.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RNXTRenovoRx, Inc.

RNXTRenovoRx, Inc.$0.91-8.05%

TVRDTvardi Therapeutics, Inc.

TVRDTvardi Therapeutics, Inc.$3.38-3.15%

LVTXLAVA Therapeutics N.V.

LVTXLAVA Therapeutics N.V.$1.74-3.87%

LTRNLantern Pharma Inc.

LTRNLantern Pharma Inc.$3.59+2.57%

XLOXilio Therapeutics, Inc.

XLOXilio Therapeutics, Inc.$8.46-0.70%

ABVCABVC BioPharma, Inc.

ABVCABVC BioPharma, Inc.$1.41+0.00%

OKUROnKure Therapeutics, Inc.

OKUROnKure Therapeutics, Inc.$4.20+1.94%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCEVirgin Galactic

SPCEVirgin Galactic$6.18+0.36%

ONDSOndas

ONDSOndas$13.22-0.00%

NOKNokia

NOKNokia$14.84-0.03%

BBAIBigBear.ai

BBAIBigBear.ai$5.04+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$46.09+0.12%

PLTRPalantir Technologies

PLTRPalantir Technologies$156.54+0.09%

TAT&T

TAT&T$24.80-0.00%

Questions About GRCE

What is the current price of Grace Therapeutics?

Grace Therapeutics is trading at $2.57 per share.

What is the 52-week range for Grace Therapeutics?

Over the past 52 weeks, Grace Therapeutics has traded between $1.79 and $5.18.

How much debt does Grace Therapeutics have?

As of the most recent reporting period, Grace Therapeutics reported total debt of $0.00.

How much cash does Grace Therapeutics have on hand?

Grace Therapeutics reported $18.67M in cash and cash equivalents in its most recent financial results.

What is Grace Therapeutics’s dividend yield?

Grace Therapeutics does not currently have a dividend yield.

Grace Therapeutics

Grace Therapeutics Financials at a Glance

GRCE News

Why Shares of Acasti Pharma Slumped Tuesday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Grace Therapeutics

GRCE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Grace Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GRCE

What is the current price of Grace Therapeutics?

What is the 52-week range for Grace Therapeutics?

How much debt does Grace Therapeutics have?

How much cash does Grace Therapeutics have on hand?

What is Grace Therapeutics’s dividend yield?

Premium Investing Services